---
document_datetime: 2025-11-23 08:06:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/clopidogrel-ratiopharm-0.html
document_name: clopidogrel-ratiopharm-0.html
version: success
processing_time: 0.0891655
conversion_datetime: 2025-12-26 17:11:55.00573
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Clopidogrel ratiopharm

[RSS](/en/individual-human-medicine.xml/65905)

##### Withdrawn

This medicine's authorisation has been withdrawn

clopidogrel

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Clopidogrel ratiopharm](#more-information-on-clopidogrel-ratiopharm-1138)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 23 September 2009, the European Commission issued a marketing authorisation valid throughout the European Union for the generic medicinal product Clopidogrel ratiopharm, which had been approved for: Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:

- Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

The marketing authorisation holder (MAH) responsible for Clopidogrel ratiopharm was Archie Samuel s.r.o..

On 25 October 2013, the European Commission issued a decision to withdraw the marketing authorisation for Clopidogrel ratiopharm, following its receipt of a letter dated 10 September 2013 notifying the Commission of the MAH's decision to voluntarily withdraw the marketing authorisation for this product for commercial reasons.

Clopidogrel ratiopharm was not marketed in any European country. Pursuant to this decision, the European public assessment report for Clopidogrel ratiopharm is updated to reflect that the marketing authorisation is no longer valid.

Clopidogrel ratiopharm : EPAR - Summary for the public

English (EN) (206.29 KB - PDF)

**First published:** 16/10/2009

**Last updated:** 12/12/2013

[View](/en/documents/overview/clopidogrel-ratiopharm-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-429)

български (BG) (288.94 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/bg/documents/overview/clopidogrel-ratiopharm-epar-summary-public_bg.pdf)

español (ES) (209.31 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/es/documents/overview/clopidogrel-ratiopharm-epar-summary-public_es.pdf)

čeština (CS) (269.97 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/cs/documents/overview/clopidogrel-ratiopharm-epar-summary-public_cs.pdf)

dansk (DA) (231.32 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/da/documents/overview/clopidogrel-ratiopharm-epar-summary-public_da.pdf)

Deutsch (DE) (212.17 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/de/documents/overview/clopidogrel-ratiopharm-epar-summary-public_de.pdf)

eesti keel (ET) (206.5 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/et/documents/overview/clopidogrel-ratiopharm-epar-summary-public_et.pdf)

ελληνικά (EL) (258.48 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/el/documents/overview/clopidogrel-ratiopharm-epar-summary-public_el.pdf)

français (FR) (209.21 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/fr/documents/overview/clopidogrel-ratiopharm-epar-summary-public_fr.pdf)

italiano (IT) (206.7 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/it/documents/overview/clopidogrel-ratiopharm-epar-summary-public_it.pdf)

latviešu valoda (LV) (242.33 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/lv/documents/overview/clopidogrel-ratiopharm-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (231.71 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/lt/documents/overview/clopidogrel-ratiopharm-epar-summary-public_lt.pdf)

magyar (HU) (241.9 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/hu/documents/overview/clopidogrel-ratiopharm-epar-summary-public_hu.pdf)

Malti (MT) (247.83 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/mt/documents/overview/clopidogrel-ratiopharm-epar-summary-public_mt.pdf)

Nederlands (NL) (208.85 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/nl/documents/overview/clopidogrel-ratiopharm-epar-summary-public_nl.pdf)

polski (PL) (278.92 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/pl/documents/overview/clopidogrel-ratiopharm-epar-summary-public_pl.pdf)

português (PT) (209.82 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/pt/documents/overview/clopidogrel-ratiopharm-epar-summary-public_pt.pdf)

română (RO) (230.91 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/ro/documents/overview/clopidogrel-ratiopharm-epar-summary-public_ro.pdf)

slovenčina (SK) (269.75 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/sk/documents/overview/clopidogrel-ratiopharm-epar-summary-public_sk.pdf)

slovenščina (SL) (258.66 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/sl/documents/overview/clopidogrel-ratiopharm-epar-summary-public_sl.pdf)

Suomi (FI) (208.19 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/fi/documents/overview/clopidogrel-ratiopharm-epar-summary-public_fi.pdf)

svenska (SV) (230.18 KB - PDF)

**First published:**

16/10/2009

**Last updated:**

12/12/2013

[View](/sv/documents/overview/clopidogrel-ratiopharm-epar-summary-public_sv.pdf)

## Product information

Clopidogrel ratiopharm : EPAR - Product Information

English (EN) (419.76 KB - PDF)

**First published:** 01/12/2009

**Last updated:** 12/12/2013

[View](/en/documents/product-information/clopidogrel-ratiopharm-epar-product-information_en.pdf-0)

**Latest procedure affecting product information:** N/0016 25/10/2013

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Clopidogrel ratiopharm : EPAR - All Authorised presentations

English (EN) (169.25 KB - PDF)

**First published:** 01/12/2009

**Last updated:** 12/12/2013

[View](/en/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_en.pdf-0)

[Other languages (21)](#file-language-dropdown-359)

български (BG) (212.12 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/bg/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_bg.pdf-0)

español (ES) (162.92 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/es/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_es.pdf-0)

čeština (CS) (231.92 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/cs/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_cs.pdf-0)

dansk (DA) (162.79 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/da/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_da.pdf-0)

Deutsch (DE) (162.47 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/de/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_de.pdf-0)

eesti keel (ET) (162.62 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/et/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_et.pdf-0)

ελληνικά (EL) (238.96 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/el/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_el.pdf-0)

français (FR) (163.18 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/fr/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_fr.pdf-0)

italiano (IT) (162.54 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/it/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_it.pdf-0)

latviešu valoda (LV) (233.88 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/lv/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_lv.pdf-0)

lietuvių kalba (LT) (230.86 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/lt/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_lt.pdf-0)

magyar (HU) (233.81 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/hu/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_hu.pdf-0)

Malti (MT) (231.19 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/mt/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_mt.pdf-0)

Nederlands (NL) (161.28 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/nl/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_nl.pdf-0)

polski (PL) (198.78 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/pl/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_pl.pdf-0)

português (PT) (162.84 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/pt/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_pt.pdf-0)

română (RO) (223.75 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/ro/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_ro.pdf-0)

slovenčina (SK) (199.64 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/sk/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_sk.pdf-0)

slovenščina (SL) (167.95 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/sl/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_sl.pdf-0)

Suomi (FI) (162.65 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/fi/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_fi.pdf-0)

svenska (SV) (178.08 KB - PDF)

**First published:**

01/12/2009

**Last updated:**

12/12/2013

[View](/sv/documents/all-authorised-presentations/clopidogrel-ratiopharm-epar-all-authorised-presentations_sv.pdf-0)

## Product details

Name of medicine Clopidogrel ratiopharm Active substance clopidogrel International non-proprietary name (INN) or common name clopidogrel Therapeutic area (MeSH)

- Peripheral Vascular Diseases
- Stroke
- Myocardial Infarction

Anatomical therapeutic chemical (ATC) code B01AC04

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:

- patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

For further information please refer to section 5.1.

## Authorisation details

EMA product number EMEA/H/C/001173

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Archie Samuel s.r.o.

Slunná 16

Marketing authorisation issued 23/09/2009 Withdrawal of marketing authorisation 25/10/2013 Revision 5

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Clopidogrel ratiopharm : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (246.88 KB - PDF)

**First published:** 01/12/2009

**Last updated:** 12/12/2013

[View](/en/documents/procedural-steps-after/clopidogrel-ratiopharm-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Clopidogrel ratiopharm-H-C-1173-A20-08 : EPAR - Assessment Report - Article 20

Adopted

English (EN) (208.73 KB - PDF)

**First published:** 30/03/2011

**Last updated:** 12/12/2013

[View](/en/documents/variation-report/clopidogrel-ratiopharm-h-c-1173-a20-08-epar-assessment-report-article-20_en.pdf)

## Initial marketing authorisation documents

Clopidogrel ratiopharm : EPAR - Public assessment report

English (EN) (383.85 KB - PDF)

**First published:** 16/10/2009

**Last updated:** 12/12/2013

[View](/en/documents/assessment-report/clopidogrel-ratiopharm-epar-public-assessment-report_en.pdf)

Committee for medicinal products for human use summary of positive opinion for Clopidogrel ratiopharm

Reference Number: EMEA/CHMP/375222/2009

English (EN) (32.81 KB - PDF)

**First published:** 25/06/2009

**Last updated:** 25/06/2009

[View](/en/documents/smop-initial/committee-medicinal-products-human-use-summary-positive-opinion-clopidogrel-ratiopharm_en.pdf)

#### More information on Clopidogrel ratiopharm

Questions and answers on the precautionary recall of batches of clopidogrel-containing medicines

Reference Number: EMA/179698/2010

English (EN) (58.98 KB - PDF)

**First published:** 25/03/2010

**Last updated:** 25/03/2010

[View](/en/documents/medicine-qa/questions-and-answers-precautionary-recall-batches-clopidogrel-containing-medicines_en.pdf)

**This page was last updated on** 12/12/2013

## Share this page

[Back to top](#main-content)